Number of pool parasite illness cases on rise Aug 8, 2008
Most people recover without treatment, but an anti-diarrheal medicine, nitazoxanide, is available. While the illness is not deemed life-threatening for people with healthy immune systems, those with weakened immune systems may develop serious or even fatal illness. (Rensselaer Republican, IN)
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008 Apr 23, 2008
Findings Include 80% SVR12 Rate with Nitazoxanide-Based Combination Therapy and New Insights into Mechanism of Action of Nitazoxanide MILAN, Italy, April 23 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, today announced that data from studies of nitazoxanide in chronic hepatitis C virus (HCV) infection are being communicated in four presentations made at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), held in Milan, Italy... (PR Newswire)
Romark Laboratories launches hepatitis C trial Apr 21, 2008
The trial will study the effectiveness of nitazoxanide, a Romark drug that has been approved previously by the U.S. Food and Drug Administration for use in treating certain types of diarrhea. The new study is a Phase II clinical trial that will enroll 60 patients at 15 centers in the United States. (Tampa Bay Business Journal, FL)
Vertexs lead drug telaprevir for the treatment of Hepatitis C will have to be monitored for the potential emergence of drug resistance, physicians say Feb 1, 2008
Romarks drug candidate Alinia (nitazoxanide), does not induce drug resistance in the same way as these new protease and polymerase inhibitors. Dr Ned Snyder, chief of Clinical Gastroenterology and Hepatology at University of Texas Medical Branch, added that Alinia is a completely different drug and a little bit of a wild card. (FT.com -- Markets)
Biotech firm chooses chief medical officer Jan 9, 2008
The company is developing nitazoxanide for treating chronic hepatitis C and other new thiazolides for treating viral diseases including hepatitis B and C and influenza. Related Industry News. (Tampa Bay Business Journal, FL)
